{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T10:49:52Z","timestamp":1766400592841},"reference-count":34,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":5871,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vet Pharm &amp; Therapeutics"],"published-print":{"date-parts":[[1992,6]]},"abstract":"<jats:p>Differences in bioavailability of many drugs from their various dosage forms have been shown to be relatively common in human medicine. Although comparable bioavailability (\u2018bioequivalence\u2019) is thought to ensure comparable clinical effectiveness and safety (\u2018therapeutic equivalence\u2019), the relationship between bioinequivalence and therapeutic inequivalence is less clear. Thus the prevalence of clinically important differences in bioavailability is unknown. While similar concerns have arisen about drug products used in small animal practice, there have been few investigations and some earlier reports are incomplete. However, there are indications of bioinequivalence with enteral formulations of ampicillin, aspirin, chloramphenicol, digoxin, rnitotane, oxytet\u2010racycline, penicillin V and theophylline. Other studies have suggested bioequivalence with enteral formulations of chloramphenicol, digoxin, phenytoin, oxytetracycline and thyroxine. Limited data for injectable preparations showed bioinequivalence with chloramphenicol and possibly oxytetracycline. There is no reason to expect formulation\u2010related bioinequivalence to be less prevalent in veterinary than in human medicine. Indeed, it may be more common in veterinary practice because other potential influences on bioavailability (food, diseases, other drugs, etc.) are frequently ignored, and cheaper generic products are often favoured for economic reasons.<\/jats:p>","DOI":"10.1111\/j.1365-2885.1992.tb01002.x","type":"journal-article","created":{"date-parts":[[2008,4,17]],"date-time":"2008-04-17T10:46:38Z","timestamp":1208429198000},"page":"151-159","source":"Crossref","is-referenced-by-count":10,"title":["Bioavailability and bioinequivalence of drug formulations in small animals*"],"prefix":"10.1111","volume":"15","author":[{"given":"A. D. J.","family":"WATSON","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_1_2_1","unstructured":"Anon.(1990)Bioequivalence Guideline. Center for Veterinary Medicine Food and Drug Administration Rockville MD USA."},{"key":"e_1_2_1_3_1","first-page":"1481","article-title":"Comparison of bioavailability of two chloramphenicol preparations in dogs after intramuscular injection.","volume":"36","author":"Bergt G.","year":"1975","journal-title":"American Journal of Veterinary Research"},{"key":"e_1_2_1_4_1","first-page":"1230","article-title":"Pharmacokinetics, bioavailability, and dosage regimens of digoxin in dogs.","volume":"41","author":"Button C.","year":"1980","journal-title":"American Journal of Veterinary Research"},{"key":"e_1_2_1_5_1","first-page":"101","article-title":"Oral absorption of different forms of ampicillin","author":"Bywater R.J.","year":"1977","journal-title":"Veterinary Record"},{"key":"e_1_2_1_6_1","first-page":"35","article-title":"Pharmacokinetic evaluation of the oral absorption of different ampicillin preparations in Beagle dogs","volume":"1969","author":"Cabana B.E.","year":"1970","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"e_1_2_1_7_1","volume-title":"Basics of Bioavailability","author":"Chodos D.J.","year":"1974"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2885.1981.tb00704.x"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2885.1979.tb00350.x"},{"key":"e_1_2_1_10_1","first-page":"734","article-title":"Plasma levels of digoxin in the cat: some clinical applications.","volume":"14","author":"Erichsen D.F.","year":"1978","journal-title":"Journal of the American Animal Hospital Association"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600660233"},{"key":"e_1_2_1_12_1","first-page":"183","article-title":"Blood levels of oxytetracycline in dogs after oral administration.","volume":"48","author":"Immelman A.","year":"1977","journal-title":"Journal of the South African Veterinary Association"},{"key":"e_1_2_1_13_1","first-page":"191","article-title":"Oxytetracycline plasma levels in dogs after intramuscular administration of two formulations.","volume":"52","author":"Immelman A.","year":"1981","journal-title":"Journal of the South African Veterinary Association"},{"key":"e_1_2_1_14_1","first-page":"120","article-title":"Bioavailability of amoxicillin, ampicillin and hetacillin in the dog.","volume":"58","author":"Keefe T.J.","year":"1977","journal-title":"Modern Veterinary Practice"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197408012910505"},{"key":"e_1_2_1_16_1","first-page":"279","article-title":"Bioinequivalence of drug products.","volume":"177","author":"Koritz G.D.","year":"1980","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2885.1986.tb00044.x"},{"key":"e_1_2_1_18_1","first-page":"327","article-title":"Comparative bioavailability of four dosage forms of digoxin in dogs.","volume":"35","author":"Krasula R.W.","year":"1976","journal-title":"Federation Proceedings"},{"key":"e_1_2_1_19_1","first-page":"1586","article-title":"Serum salicylate concentrations and endoscopic evaluation of the gastric mucosa in dogs after oral administration of aspirin\u2010containing products.","volume":"47","author":"Lipowitz A.J.","year":"1986","journal-title":"American Journal of Veterinary Research"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2885.1990.tb00793.x"},{"key":"e_1_2_1_21_1","first-page":"47","article-title":"Chloramphenicol blood concentration studies in dogs.","volume":"158","author":"Mercer H.D.","year":"1971","journal-title":"Journal of the American Veterinary Meakal Association"},{"key":"e_1_2_1_22_1","first-page":"1353","article-title":"Bioavailability and pharmacokinetics of several dosage forms of ampicillin in the cat.","volume":"38","author":"Mercer H.D.","year":"1977","journal-title":"American Journal of Veterinary Research"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2885.1990.tb00762.x"},{"key":"e_1_2_1_24_1","first-page":"215","volume-title":"Proceedings of the Eighth Conference","author":"Overduin L.M.","year":"1988"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0034-5288(18)31157-3"},{"key":"e_1_2_1_26_1","first-page":"292","article-title":"Physicochemical factors influencing the absorption of the anhydrous and trihydrate forms of ampicillin.","volume":"10","author":"Poole J.W.","year":"1968","journal-title":"Current Therapeutic Research"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2885.1984.tb00885.x"},{"key":"e_1_2_1_28_1","first-page":"182","volume-title":"Drug Treatment\u2014Principles and Practice of Clinical Pharmacology and Therapeutics","author":"Wade D.N.","year":"1980"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-0813.1973.tb09292.x"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2885.1979.tb00363.x"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2885.1980.tb00414.x"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2885.1980.tb00478.x"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0034-5288(18)30766-5"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2885.1987.tb00098.x"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600790210"}],"container-title":["Journal of Veterinary Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2885.1992.tb01002.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2885.1992.tb01002.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T12:14:24Z","timestamp":1698063264000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2885.1992.tb01002.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,6]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1992,6]]}},"alternative-id":["10.1111\/j.1365-2885.1992.tb01002.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2885.1992.tb01002.x","archive":["Portico"],"relation":{},"ISSN":["0140-7783","1365-2885"],"issn-type":[{"value":"0140-7783","type":"print"},{"value":"1365-2885","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,6]]}}}